European cooperation could help to lower drug pricesBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1584 (Published 10 September 2008) Cite this as: BMJ 2008;337:a1584
- Timothy D Heymann, reader in health management1
- 1Business School, Imperial College, London SW7 2AZ
The National Institute for Health and Clinical Excellence (NICE) acknowledges that thought should be given not only to a drug’s effectiveness and quality adjusted life year (QALY) value but also to ways to influence the drug’s cost.1 But in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial